BSC-2201

N/A

Report date: 2024/12/20 15:20:22
NME

Base Information

Drug NameBSC-2201
Drug Alias NameBSC-2201
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiSiChem Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiSiChem Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A